BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan T, Lu Z, Liu Y, Wang L, Tian H, Zheng Y, Zheng B, Xue L, Tan F, Xue Q, Gao S, Li C, He J. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis. Front Immunol 2021;12:665407. [PMID: 34177903 DOI: 10.3389/fimmu.2021.665407] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Zhao D, Shan Y, Cui W, Xie Q, Jiang J, Peng W, Zhang C, Duan C. Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients. Sci Rep 2022;12:20737. [PMID: 36456645 DOI: 10.1038/s41598-022-23140-w] [Reference Citation Analysis]
2 Su X, Gao H, Qi Z, Xu T, Wang G, Luo H, Cheng P. Prediction of immune subtypes and overall survival in lung squamous cell carcinoma. Curr Med Res Opin 2022;:1-22. [PMID: 36245361 DOI: 10.1080/03007995.2022.2129231] [Reference Citation Analysis]
3 Zhang P, Gao H, Ye C, Yan R, Yu L, Xia C, Yang D. Large-Scale Transcriptome Data Analysis Identifies KIF2C as a Potential Therapeutic Target Associated With Immune Infiltration in Prostate Cancer. Front Immunol 2022;13:905259. [PMID: 35720323 DOI: 10.3389/fimmu.2022.905259] [Reference Citation Analysis]
4 Luo P, Jiang Y, Ding S, Jiang S, Tang R, Tang Z, Cai Y. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma. BioMed Research International 2022;2022:1-14. [DOI: 10.1155/2022/4944758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yang J, Wu Z, Yang L, Jeong JH, Zhu Y, Lu J, Wang B, Wang N, Wang Y, Shen K, Li R. Characterization of Kinesin Family Member 2C as a Proto-Oncogene in Cervical Cancer. Front Pharmacol 2021;12:785981. [PMID: 35153749 DOI: 10.3389/fphar.2021.785981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Sasa GBK, Xuan C, Chen M, Jiang Z, Ding X. Clinicopathological implications of lncRNAs, immunotherapy and DNA methylation in lung squamous cell carcinoma: a narrative review. Transl Cancer Res 2021;10:5406-29. [PMID: 35116387 DOI: 10.21037/tcr-21-1607] [Reference Citation Analysis]